PGX HEALTH LLC has a total of 17 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Canada and China. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ARGENTA ORAL THERAPEUTICS LTD, BEZENCON OLIVIER and SGX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 3 | |
#3 | China | 2 | |
#4 | South Africa | 2 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars | |
#4 | Microorganisms | |
#5 | Animal care | |
#6 | Climate change adaptation technologies | |
#7 | Measuring microorganism processes | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Thompson Robert D | 12 |
#2 | Rieger Jayson M | 12 |
#3 | Wang Guoquan | 8 |
#4 | Beauglehole Anthony | 2 |
#5 | Guoquan Wang | 1 |
#6 | Eiselt Regina | 1 |
#7 | Pickersgill Iain F | 1 |
#8 | Wojnowski Leszek | 1 |
#9 | Cheesman Edward H | 1 |
Publication | Filing date | Title |
---|---|---|
CN101466382A | Substituted 8-amino-3-pyridyl]xanthines | |
CN101490075A | Substituted aryl piperidinylalkynyladenosines as A2AR agonists | |
US2007270373A1 | Substituted aryl piperidinylalkynyladenosines as A2AR agonists | |
US2007105821A1 | Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |